Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Ultragenyx Pharmaceutical Inc. logo

Ultragenyx Pharmaceutical Inc.

Sector: Healthcare   

Industry: Biotechnology

46.69
 
USD
  
-0.13
  
(-0.28%)
Optionable: Yes  Market Cap: 3,743 M  90-day average vol: 760,126

Previous close: 46.82  Open: 46.91  Bid: 45.3  Ask: 48.81
52 week range    
31.52   
   54.98
Peers   
BMRN / 
FOLD / 
ESPR / 
Last updated: Friday 29th March 2024
35
MarketXLS Rank
40
Value
23
Technical
44
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BMRN

16 B886.389.37

ESPR

0 B-0.43.42

FOLD

3 B-10.59.26

LXRX

0 B-6.73.1
Financials

RARE Income Statement

Annual
Invalid dateDec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
AccretionOnPreferredStock0.0
Amortization of intangibles44 M131 M160 M
Basic EPS from continuing operations-7.12-3.07-6.7-10.12
Basic EPS total-1.73-7.12-3.07-6.7-10.12
Basic weighted shares outstanding29 M37 M40 M42 M50 M57 M61 M68 M70 M
Cost of sales-1000.0-1 M
Depreciation-684000.0-1 M0.0
DepreciationAndAmortization-684000.0-1 M-3 M
Diluted EPS total-2.25-3.96-6.21-7.12-3.97-7.12-3.07-6.7-10.12
Diluted normalized net income/share-10.12
Diluted weighted shares outstanding27 M37 M40 M42 M50 M57 M61 M70 M
Dividends paid per share0.00.0
GainOnSaleOfPPE170 M
GainOnSaleOfSecurity0.00.00.00.00.013 M170 M-42 M-19 M
GeneralAndAdministrativeExpense11 M33 M-3 M-4 M-6 M162 M183 M220 M278 M
Gross operating profit133000.03 M51 M104 M271 M351 M363 M
ImpairmentOfCapitalAssets0.0
Income before tax-60 M-146 M-246 M-318 M-197 M-399 M-185 M-453 M-702 M
Income restructuring and M&A-307 M-342 M
Income taxes0.00.035000.0-16 M514000.03 M1 M1 M6 M
Interest income608000.02 M4 M4 M10 M13 M7 M2 M11 M
InterestExpenseNonOperating40000.058000.037000.0
MiscOtherSpecialCharges-4 M-200000.0-2 M7 M-6 M-787000.0607000.0-2 M-2 M
Net income from total operations-60 M-146 M-246 M-302 M-198 M-403 M-187 M-454 M-707 M
NetIncomeCommonStockholders-60 M-146 M-246 M-302 M-198 M-384 M-141 M-393 M-608 M
NetIncomeContinuousOperations-60 M-146 M-246 M-302 M-198 M-403 M-187 M-454 M-707 M
NetNonOperatingInterestIncomeExpense608000.02 M4 M4 M10 M13 M7 M2 M11 M
Normalized income-358 M-554 M
Operating income-57 M-148 M-248 M-329 M-371 M-424 M-330 M-382 M-649 M
Operating income before depreciation (EBITDA)-56 M-139 M-238 M-311 M-180 M-397 M-172 M-433 M-681 M
OperatingExpense-57 M-148 M-248 M-332 M-423 M528 M589 M701 M956 M
Other income net4 M200000.02 M-7 M-165 M-13 M-171 M44 M21 M
OtherGandA11 M33 M-3 M-4 M-6 M162 M183 M220 M278 M
OtherOperatingExpenses-57 M-148 M-248 M-332 M1 M-9 M-7 M-9 M-11 M
OtherunderPreferredStockDividend-5 M
PreferredStockDividends-5 M
RentAndLandingFees11 M33 M-3 M-4 M-6 M
Research & development expense46 M115 M183 M232 M294 M357 M412 M497 M706 M
ResearchExpense46 M115 M183 M232 M294 M357 M412 M497 M706 M
RestructringAndMnAIncome-307 M-342 M
Revenue per share44 M158000.0131 M160 M
SalariesAndWages-5 M-25 M-48 M-68 M-80 M-6 M-16 M-28 M
Selling Gen & administrative expense11 M33 M65 M100 M128 M162 M183 M220 M278 M
SellingAndMarketingExpense65 M100 M128 M
SellingExpense65 M100 M128 M
Special income/charges307 M342 M
Total Income available for interest expense (EBIT)-60 M-146 M-246 M-318 M-197 M-399 M-185 M-453 M-702 M
Total common shares outstanding36 M39 M42 M50 M51 M58 M67 M69 M70 M
Total net income-60 M-146 M-246 M-302 M-198 M-403 M-187 M-454 M-707 M
Total ordinary shares82 M82 M82 M82 M82 M82 M82 M82 M82 M
Total revenues133000.03 M51 M104 M271 M351 M363 M
TotalExpenses-57 M-148 M-248 M-332 M-423 M528 M589 M701 M956 M
TotalRevenue133000.03 M51 M104 M271 M351 M363 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University